Exclusive | Merck Creates Separate Cancer Business as Sales Pressure Looms
The drugmaker is splitting its pharmaceuticals unit to bolster product launches before a crucial patent loss.
The drugmaker is splitting its pharmaceuticals unit to bolster product launches before a crucial patent loss.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
